Literature DB >> 17948006

Protocol for preparing proteins with improved solubility by co-expressing with molecular chaperones in Escherichia coli.

Ario de Marco1.   

Abstract

Eight combinations of molecular chaperones (e.g., DnaK/DnaJ/GrpE/ClpB) are co-expressed with the target recombinant protein to compare their effectiveness in improving its soluble yield. This system allows the most complete and rational approach proposed so far to use the chaperone activity for optimizing the host cell folding machinery. Furthermore, a two-step protocol is presented, in which protein synthesis and protein refolding are uncoupled. Molecular chaperones and target protein accumulate in the first growth phase and target protein aggregates are then disaggregated in vivo after the block of protein synthesis. The optimal chaperone combination to maximize the soluble yield of a specific protein remains unpredictable. Therefore, a small-scale purification selection step is useful for screening among expression combinations before scaling-up production. Applying such a strategy, we could increase the solubility of 70% of the tested constructs with yields of up to 42-fold more protein than in controls. The procedure takes 2 d.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17948006     DOI: 10.1038/nprot.2007.400

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  41 in total

1.  Development and Evaluation of CmeC Subunit Vaccine against Campylobacter jejuni.

Authors:  Ximin Zeng; Fuzhou Xu; Jun Lin
Journal:  J Vaccines Vaccin       Date:  2010-01-01

2.  Rehosting of bacterial chaperones for high-quality protein production.

Authors:  Mónica Martínez-Alonso; Verónica Toledo-Rubio; Rob Noad; Ugutz Unzueta; Neus Ferrer-Miralles; Polly Roy; Antonio Villaverde
Journal:  Appl Environ Microbiol       Date:  2009-10-09       Impact factor: 4.792

3.  Cross-system excision of chaperone-mediated proteolysis in chaperone-assisted recombinant protein production.

Authors:  Mónica Martínez-Alonso; Antonio Villaverde; Neus Ferrer-Miralles
Journal:  Bioeng Bugs       Date:  2009-12-29

4.  Individual and collective contributions of chaperoning and degradation to protein homeostasis in E. coli.

Authors:  Younhee Cho; Xin Zhang; Kristine Faye R Pobre; Yu Liu; David L Powers; Jeffery W Kelly; Lila M Gierasch; Evan T Powers
Journal:  Cell Rep       Date:  2015-04-02       Impact factor: 9.423

Review 5.  A Review: Molecular Chaperone-mediated Folding, Unfolding and Disaggregation of Expressed Recombinant Proteins.

Authors:  Komal Fatima; Fatima Naqvi; Hooria Younas
Journal:  Cell Biochem Biophys       Date:  2021-02-25       Impact factor: 2.194

6.  Co-expression of chaperones from P. furiosus enhanced the soluble expression of the recombinant hyperthermophilic α-amylase in E. coli.

Authors:  Shuaiying Peng; Zhongmei Chu; Jianfeng Lu; Dongxiao Li; Yonghong Wang; Shengli Yang; Yi Zhang
Journal:  Cell Stress Chaperones       Date:  2016-02-10       Impact factor: 3.667

Review 7.  Side effects of chaperone gene co-expression in recombinant protein production.

Authors:  Mónica Martínez-Alonso; Elena García-Fruitós; Neus Ferrer-Miralles; Ursula Rinas; Antonio Villaverde
Journal:  Microb Cell Fact       Date:  2010-09-02       Impact factor: 5.328

8.  Cell-free production of transducible transcription factors for nuclear reprogramming.

Authors:  William C Yang; Kedar G Patel; Jieun Lee; Yohannes T Ghebremariam; H Edward Wong; John P Cooke; James R Swartz
Journal:  Biotechnol Bioeng       Date:  2009-12-15       Impact factor: 4.530

9.  Identification and characterization of re-citrate synthase in Syntrophus aciditrophicus.

Authors:  Marie Kim; Huynh Le; Michael J McInerney; Wolfgang Buckel
Journal:  J Bacteriol       Date:  2013-02-01       Impact factor: 3.490

10.  Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli.

Authors:  Kamal Veisi; Safar Farajnia; Nosratollah Zarghami; Hamid Reza Khoram Khorshid; Nasser Samadi; Shiva Ahdi Khosroshahi; Hossein Zarei Jaliani
Journal:  Adv Pharm Bull       Date:  2015-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.